Biotech SF
San Francisco Bay Area biotech stories.
Tuesday, February 1, 2011
Allergan, Map Pharmaceuticals in migraine drug deal worth up to $157M
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment